Drug

Rare Disease Drug Gets Tailored FDA Guidance Before Pivotal Trials

Business Pen
[stock_market_widget type=”card” template=”basic2″ assets=”IRD” realtime=”true” api=”yahoo-finance”] An early-stage gene-therapy program targeting a rare form of childhood blindness has quietly entered a new lane inside the...

Alzheimer’s Drug Trial Failure Sends Novo Nordisk Stock Tumbling

Business Pen
[stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk A/S (NASDAQ: NVO) recently encountered a notable setback that sent ripples through its stock price and raised...

Subscribe to Newsletter